Clinical Trials Using LSD1 Inhibitor IMG-7289

Clinical trials are research studies that involve people. The clinical trials on this list are studying LSD1 Inhibitor IMG-7289. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • IMG-7289 in Patients With Myelofibrosis

    This is a Phase 2b open label study of an orally administered LSD1 inhibitor, IMG-7289, in patients with myelofibrosis. This study investigates the following: - The safety and tolerability of IMG-7289 - The pharmacokinetics of IMG-7289 (performed in Phase 1 / 2a only) - The pharmacodynamic effect of IMG-7289
    Location: 7 locations